Siegbahn, A.

patient level mortality quartile marker troponin nt-probnp treatment study abciximab troponin t heart baseline group elevation syndrome artery disease c-reactive protein trial 30 days disease protein 0.001 coagulation angina artery death circulation flammation randomized treatment groups c-reactive gusto-iv result natriuretic creatinine peptide infarction event relation value signi table nt-probnp levels /iiia creatinine clearance clearance 1- year mortality randomized heart failure 72 hours abciximab infusion inhibitor system ͻ0.001 predictor st-segment effect platelet depression combination heart rate 24 hours 30- day mortality analyses st-segment depression crp levels outcome flammatory dalteparin association regression analysis brinolysi activation prognostic regression figure fi brinolysis systems substudy infusion relationship